Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

313.50p
   
  • Change Today:
    -0.50p
  • 52 Week High: 445.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 106.09m
  • Volume: 25,527
  • Market Cap: £332.60m
  • RiskGrade: 125
  • Beta: 0.00

Latest ShareCast News

Oxford Biomedica reports first-half revenue growth

By Josh White

Date: Monday 23 Sep 2024

(Sharecast News) - Oxford Biomedica, a prominent gene and cell therapy company, reported significant revenue growth alongside strategic advancements in its interim results on Monday.

OXB Regulatory News

Director/PDMR Shareholding 17-Jun-2025 18:00 RNS
Result of Annual General Meeting 11-Jun-2025 18:02 RNS
AGM Update 11-Jun-2025 07:02 RNS
Holding(s) in Company 10-Jun-2025 10:49 RNS
Block Listing Application 05-Jun-2025 07:00 RNS

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 313.50p
Change Today -0.50p
% Change -0.16 %
52 Week High 445.00
52 Week Low 232.50
Volume 25,527
Shares Issued 106.09m
Market Cap £332.60m
Beta 0.00
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.81% below the market average29.81% below the market average29.81% below the market average29.81% below the market average29.81% below the market average
21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average
Price Trend
46.64% below the market average46.64% below the market average46.64% below the market average46.64% below the market average46.64% below the market average
4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average
Income Not Available
Growth
3.31% above the market average3.31% above the market average3.31% above the market average3.31% above the market average3.31% above the market average
9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 19-Jun-2025

Time Volume / Share Price
16:35 6,530 @ 313.50p
16:35 443 @ 313.50p
16:35 20 @ 313.50p
16:35 7 @ 313.50p
16:35 23 @ 313.50p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page